PHBR, IMDS, BRGO, MDHI, OPTT, GNOM
Our Stocks to Watch today include PhoneBrasil International Inc. (OTC: PHBR), Imaging Diagnostic Systems Inc. (OTCBB: IMDS), Bergio International Inc. (OTCBB: BRGO), Medical Alarm Concepts Holding Inc. (OTC: MDHI), Ocean Power Technologies Inc. (Nasdaq: OPTT) and Complete Genomics Inc. (Nasdaq: GNOM).
PHONEBRASIL INTERNATIONAL INCORPORATED (OTC: PHBR)
"Up 127.27% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PHBR.php
PhoneBrasil International Inc. offers internet broadcasting and telecommunication services. The company provides internet and wireless communication services. It partners with CIMA Telecom and CityNet Wireless. PhoneBrasil International Inc. is headquartered in Doral, Florida with additional operations in Brazil.
July 11 - PhoneBrasil International Inc. Returns to Brazil
The Phone Brasil Group, doing business as PhoneBrasil International Inc. (OTC: PHBR), announced that it is returning to Brazil as a fully licensed and operational telecommunications company servicing nationwide the domestic consumer and enterprise markets in Brazil.
Anderson Dias, CEO of Phone Brasil, assured the Company's shareholders that the lack of communications in the last few years will not occur in the future. Mr. Anderson went on to state that the Board of Directors of the Company has adopted a policy, which ensures total transparency in the future.
Mr. Anderson went on assuring that the company has been hard at work securing the proper licenses and government permission to enter the telecommunications market in Brazil, a goal now accomplished with its national licenses allowing PhoneBrasil Inc. to sell wireless broadband Internet access and phone services as well as the more traditional fixed line broadband and phone services geared to both consumers and business entities in Brazil.
The Company also announced that it plans to be operational and servicing clients via a WiMAX nationwide network beginning January 1, 2013. Mr. Dias also stated that its sales teams have begun the task of securing its network of agents and distributors nationwide to help market its products. The main product will be marketed under the Connect 3S brand.
PhoneBrasil International expects to secure several of the opportunities that are presented as the country gets ready for the Soccer World Cup in 2014 and the Summer Olympics in 2016. Mr. Dias stated: "We are pleased with our progress and exited to begin pleasing our customers in January 2013."
IMAGING DIAGNOSTIC SYSTEMS (OTCBB: IMDS)
"Up 35.29% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IMDS.php
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM® system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM®) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.
No recent news for Imaging Diagnostic Systems, Inc. (OTCBB: IMDS).
BERGIO INTERNATIONAL INCORPORATED (OTCBB: BRGO)
"Up 8.70% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/BRGO.php
Bergio International, Inc. a leading jeweler creating a diversified jewelry designer and manufacturer through acquisitions and consolidation in the estimated $160 billion a year highly fragmented independently owned jewelry industry Bergio currently sells its jewelry to approximately 50 jewelry retailers across the United States. Bergio has manufacturing control over its line through its manufacturing facility in New Jersey, as well as subcontracts with facilities in the United States and Italy.
June 14 - Bergio International Announces JCK Trade Show Results
Bergio International, Inc. (OTCBB: BRGO) ("Bergio" or the "Company") announced that the 2012 "JCK" trade show which was held in Las Vegas, Nevada was very successful.
Berge Abajian, CEO of Bergio International, states, "I'm very excited about this year's sales results from the JCK show. Sales doubled from the same show last year. In addition, we are in the final stage of negotiations with a large National jewelry retail chain which will give Bergio sizable exposure throughout the United States."
He continued, "I would like to reiterate, management has no control over the performance of the stock price but we are working diligently on improving our revenue and bottom line to turn the company profitable. Looking at this year's results from the show and the final negotiation with the retail chain, Bergio is on its way to achieving its goals."
MEDICAL ALARM CONCEPTS HOLDING INCORPORATED (OTC: MDHI)
"Up 58.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MDHI.php
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's™ patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant™ service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time. Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
July 12 - MDHI Enhances Service Offerings with New Options for Customers of America's Largest Warehouse Club Chain - Announces New Extended Concierge Services
Medical Alarm Concepts Holding, Inc. (OTC: MDHI) announced significant upgrades to its service offerings for the customers of the nation's second largest retailer and largest warehouse club chain. These enhancements include contract extensions options and new enhanced concierge services, which will provide unparalleled levels of services for MediPendant customers.
The Company recently launched a strategic alliance partnership with the largest warehouse club store in the United States for sales of the Company's MediPendant™ product. This program is now operational with orders being received and shipped on a daily basis. The base pricing for the service allows customers to receive the industry's most state of the art medical alarm at a price that is lower than competitive offerings which include the older medical alarm technologies. At the request of our partner, and with the contract extension options being announced today, MediPendant customers will be able to extend their contract terms at pricing that is the most competitive in the medical alarm industry.
"We are seeing strong and consistent order flow from this retailer relationship. At least 70% of customers are asking us for rates for longer contract periods," commented Ronnie Adams CEO. "We are happy to accommodate this by offering contract extensions at an extremely competitive price that will be difficult for the competition to beat or match. Best of all for our customers are that they receive a second-generation medical alarm unit that allows for true monitored speak-and-listen technology through a pendant with voice prompts that let them know their emergency call is being connected. We are the only company in the industry able to offer this patented technology. Revenues from these high margin extended contracts will belong exclusively to MDHI."
Medical Alarm Concepts is also today announcing enhanced concierge services for its customers. Priced at $9.95 per month these services offer MediPendant customers and their families enhanced safety, security and convenience. For this monthly rate customers will receive the option to have the MediPendant user called once per month from the MDHI call center to check on the status of the customer and to ensure the MediPendant is in full operation. Additionally, loved ones will receive a text message on their mobile device in the event the alarm is activated and the user will receive a medical identification bracelet that will provide vital information to emergency services personnel in case an emergency occurs when the user is away from the home.
Mr. Adams continued, "The customers we are signing up through our new retailer program are keenly interested in contract extensions. By providing these requested longer contract times we will be able to grow our revenue base faster and because the services offer very high margins our profitability will be meaningfully enhanced. Providing the concierge service is an additional avenue for us to expand our revenues even faster in order to reach profitability by our projected goal of the end of the third quarter. Our business continues to trend in positive directions as we have enhanced our marketing programs and significantly restructured our balance sheet."
OCEAN POWER TECHNOLOGIES INCORPORATED (NASDAQ: OPTT)
"Up 51.63% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/OPTT.php
Ocean Power Technologies, Inc. (OPTT) is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable and clean and environmentally-beneficial electricity. OPT has a strong track record in the advancement of wave energy and participates in an estimated $150 billion annual power generation equipment market. OPT's proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and convert predictable wave energy into clean electricity. The Company is widely recognized as a leading developer of on-grid and autonomous wave-energy generation systems, benefiting from 15 years of in-ocean experience. OPT is headquartered in Pennington, New Jersey, USA with an office in Warwick, UK.
July 9 - Ocean Power Technologies and Lockheed Martin to Develop Wave-Energy Project in Australia
Ocean Power Technologies, Inc. (Nasdaq: OPTT), a leading wave energy technology company, and Lockheed Martin (LMT) have entered into a teaming agreement with the goal of developing a 19 megawatt wave-energy project in Victoria, Australia. This is one of the largest wave-energy projects announced to date, and leverages a grant from the Commonwealth of Australia.
For the project, Lockheed Martin will assist with the design of Ocean Power Technologies' (OPT) PowerBuoy® technology, lead the production and system integration of the wave-energy converters and support overall program management. Lockheed Martin and OPT have been collaborating since 2004, first on the development of an Advanced Deployable System for the U.S. Navy and most recently to design and launch utility-scale wave energy converters off the coast of Reedsport, Oregon.
"Lockheed Martin is applying its expertise to commercialize promising, emerging alternative energy technologies," said Dan Heller, vice president of new ventures for Lockheed Martin's Mission Systems & Sensors business. "We see great potential in harnessing the vast power of the ocean. By working with OPT and Australian industry on this project, we will advance wave energy in Australia and globally."
According to the World Energy Council, wave energy has the potential to produce around 2,000 terawatt hours of electricity a year, or enough power to meet 10 percent of the world's current energy needs. In Australia, which has very attractive wave resources, this percentage could be significantly higher.
Charles F. Dunleavy, Chief Executive Officer of OPT, said, "Lockheed Martin's commitment to alternative energy and its engineering, production, and systems integration expertise will provide momentum to our Australia initiatives, where both companies see great potential for large-scale wave energy generation. We also appreciate the Commonwealth government's continued support of this project, which we expect to create a significant number of local jobs as we develop and maintain operations over the life of the power station."
Funding for the project, which is to be located off the coast of Portland, Victoria, also includes a previously announced grant of A$66.5 million ($65.3 million USD) from the Commonwealth of Australia's Department of Resources, Energy and Tourism. A Funding Deed sets out the terms of the grant, including the requirement to obtain significant additional project financing.
The project is to be developed by a special purpose Australian company, Victorian Wave Partners Pty Ltd, currently owned by Ocean Power Technologies (Australasia) Pty Ltd. The partners are assessing financing opportunities for the project and pursuing power purchase agreements with local industry and utilities.
ABOUT LOCKHEED MARTIN
Headquartered in Bethesda, Md., Lockheed Martin is a global security and aerospace company that employs about 123,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation's net sales for 2011 were $46.5 billion.
COMPLETE GENOMICS INCORPORATED (NASDAQ: GNOM)
"Up 39.15% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/GNOM.php
Through its pioneering sequencing-as-a-service model, Complete Genomics provides the most accurate whole human genomes generally available today. The ease of use and power of Complete's advanced informatics and analysis systems provide genomic information needed to better understand the prevention, diagnosis, and treatment of diseases.
July 11 - Complete Genomics Announces New Technology Developed to Set Standard for Clinical-Grade Genomes
Long Fragment Read Technology Described in Nature Paper Provides Much Higher Accuracy Sequencing
Complete Genomics, Inc. (Nasdaq: GNOM) announced that its Long Fragment Read (LFR) technology for whole genome sequencing dramatically improves accuracy, enables fully-phased genomes, and significantly reduces the amount of DNA required for testing. Complete's LFR technology should accelerate the use of whole genome sequencing by physicians to diagnose and treat their patients.
"We expect the introduction of this technological breakthrough to accelerate the move of whole genome sequencing into patient care, which in turn will begin to change the face of medicine," said Dr. Clifford Reid, Complete Genomics' chairman, president and CEO.
"The Nature paper by Peters et al. describes how our LFR technology uses 'barcoded' DNA to generate whole genome sequencing with approximately one error in 10 million base pairs, or just 600 errors in an entire human genome," said Dr. Rade Drmanac, the company's chief scientific officer and inventor of the LFR technology. "This represents a 10-fold increase in accuracy for Complete and is unmatched by any high-sensitivity method currently available."
Until now, determining whether two disease-associated variants were on the same or different parental chromosomes was either impossible or required expensive, low-throughput technologies -- an approach often infeasible in a clinical environment. Complete's new LFR technology not only enables an accurate identification of mutations, but includes phasing that shows which mutations are in fact together on the same parental chromosome. Through phasing, a physician can determine whether a patient with two pathogenic variants in a gene including its regulatory regions is affected or merely a carrier of the trait. In addition, Complete's LFR technology provides, for the first time, accurate whole-genome sequencing from as few as 10 to 20 cells (only 100 picograms of DNA), making it an ideal choice for small sample clinical sequencing applications including circulating tumor cells, fine needle aspirations, and pre-implantation genetic diagnostics.
"In the not-too-distant future, failure to use phasing when providing genomic diagnoses in patient care will be seen as unacceptably inaccurate," said Dr. George Church, professor of genetics at Harvard Medical School and director of PersonalGenomes.org. "I also suspect that LFR will reveal surprising things we didn't know were missing because we didn't have a tool to see them."
The U.S. Patent and Trademark Office has already issued Complete Genomics two separate patents on LFR technology, and additional patent applications, including miniaturization using nanodrops, are pending. Complete Genomics plans to incorporate the new technology into its sequencing offerings in early 2013.